Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

WNT7A gene expression is higher in early stages of androgenetic alopecia, showing the role of WNT pathway, apoptosis, and inflammation in the disorder.

This rare genetic disorder causes permanent hair loss and skin bumps from birth.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

The document focused on hair disorders, especially alopecia, and discussed treatments and impacts on quality of life.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

The document explains breast development, common breast conditions, and their treatments.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

Acetylcholine receptors might be involved in the development of acne inversa and smoking could worsen the condition.

Stress may contribute to the development of hypothyroidism, and both modern and Ayurvedic treatments can manage the condition.

iPSCs help understand and treat neurodevelopmental disorders.

Myrtle has various health benefits and potential for medicine development.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

The infant with a urea cycle disorder improved with treatment and a liver transplant.

The document concludes that specific hair and blood vessel abnormalities in infants with seizures and developmental issues may indicate Menkes disease, which lacks a cure and is often fatal by age 3.

Insulin resistance significantly contributes to the development and severity of certain chronic skin diseases.

A new genetic mutation in the hairless gene causes a rare hair loss disorder.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

The newborn was diagnosed with a rare skin disorder causing blisters, which requires careful wound care and family support.

Eclipta alba has many health benefits and contains compounds with potential for drug development.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

A mutation in the KRT71 gene causes a hair disorder by disrupting hair follicle structure and texture.

Histone demethylases play a key role in the development of many diseases and may be targets for treatment.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Microneedle patches could replace injections but need more development for better use in medicine.

PPARs help regulate skin health and could be used to treat skin disorders.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.